DNA Chip Research Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Ryo Matoba

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	14.4yrs
CEO sahipliği	0.1%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	5.4yrs

Son yönetim güncellemeleri

Recent updates

CEO

Ryo Matoba (59 yo)

14.4yrs

Görev süresi

Mr. Ryo Matoba, Ph.D. has been the President of DNA Chip Research Inc. since June 2010 and has been its Chief Executive Officer since June 2012. Mr. Matoba has been a Representative Director of DNA Chip Re...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Ryo Matoba	Chairman	17.4yrs	Veri yok	0.13% ¥ 6.1m
Kenichi Matsubara	Founder & Honorary Director	no data	Veri yok	Veri yok
Keiji Sato	GM of Diagnostic Business Headquarters & Director	5.4yrs	Veri yok	0.19% ¥ 8.8m
Setsuko Hashimoto	Alternate Director	no data	Veri yok	Veri yok
Shoko Kawamoto	Independent Outside Director	3.4yrs	Veri yok	Veri yok
Tomoyuki Okamura	Independent Outside Director	no data	Veri yok	Veri yok

5.4yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 2397 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.4 yıldır).

DNA Chip Research Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Insufficient new directors

DNA Chip Research Inc., Annual General Meeting, Jun 26, 2024

DNA Chip Research Inc., Annual General Meeting, Jun 21, 2023

DNA Chip Research Inc., Annual General Meeting, Jun 22, 2022

Recent updates

Second quarter 2025 earnings released: JP¥1.63 loss per share (vs JP¥10.24 loss in 2Q 2024)

DNA Chip Research Inc. to Report Q2, 2025 Results on Nov 07, 2024

First quarter 2025 earnings released: JP¥2.96 loss per share (vs JP¥15.11 loss in 1Q 2024)

New major risk - Share price stability

Insufficient new directors

Full year 2024 earnings released: JP¥39.02 loss per share (vs JP¥61.70 loss in FY 2023)

DNA Chip Research Inc., Annual General Meeting, Jun 26, 2024

New minor risk - Shareholder dilution

DNA Chip Research Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Third quarter 2024 earnings released: JP¥11.97 loss per share (vs JP¥18.70 loss in 3Q 2023)

DNA Chip Research Inc. announced that it expects to receive ¥269.99972 million in funding from Mitsui Chemicals, Inc.

New minor risk - Share price stability

DNA Chip Research Inc. to Report Q3, 2024 Results on Feb 08, 2024

Second quarter 2024 earnings released: JP¥10.24 loss per share (vs JP¥16.91 loss in 2Q 2023)

DNA Chip Research Inc. to Report Q2, 2024 Results on Nov 02, 2023

First quarter 2024 earnings released: JP¥15.11 loss per share (vs JP¥18.65 loss in 1Q 2023)

DNA Chip Research Inc. to Report Q1, 2024 Results on Jul 27, 2023

Full year 2023 earnings released: JP¥61.70 loss per share (vs JP¥23.15 loss in FY 2022)

DNA Chip Research Inc., Annual General Meeting, Jun 21, 2023

Third quarter 2023 earnings released: JP¥18.70 loss per share (vs JP¥6.74 loss in 3Q 2022)

DNA Chip Research Inc. announced that it expects to receive ¥279.99974 million in funding from Mitsui Chemicals, Inc.

DNA Chip Research Inc. to Report Q3, 2023 Results on Jan 24, 2023

Second quarter 2023 earnings released: JP¥16.91 loss per share (vs JP¥10.19 loss in 2Q 2022)

DNA Chip Research Inc. to Report Q2, 2023 Results on Oct 28, 2022

First quarter 2023 earnings released: JP¥18.65 loss per share (vs JP¥12.61 loss in 1Q 2022)

DNA Chip Research Inc. to Report Q1, 2023 Results on Jul 28, 2022

DNA Chip Research Inc., Annual General Meeting, Jun 22, 2022

Full year 2022 earnings released: JP¥23.15 loss per share (vs JP¥30.30 loss in FY 2021)

DNA Chip Research Inc. to Report Fiscal Year 2022 Results on Apr 28, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: JP¥10.19 loss per share (vs JP¥10.36 loss in 2Q 2021)

First quarter 2022 earnings released: JP¥12.61 loss per share (vs JP¥13.12 loss in 1Q 2021)

Full year 2021 earnings released: JP¥30.30 loss per share (vs JP¥25.15 loss in FY 2020)

DNA Chip Research Inc. to Report Fiscal Year 2021 Results on Apr 22, 2021

Third quarter 2021 earnings released: JP¥8.46 loss per share (vs JP¥11.40 loss in 3Q 2020)

Third quarter 2021 earnings released: JP¥8.46 loss per share

DNA Chip Research Inc. to Report Q3, 2021 Results on Jan 21, 2021

New 90-day low: JP¥644

New 90-day low: JP¥747

DNA Chip Research Inc. to Report Q2, 2021 Results on Oct 22, 2020

CEO

Görev süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş